To test this, we conducted combined experiments using DAC with radiotherapy, which demonstrated that DAC effectively reduced TFAP2C methylation levels, restored its expression, increased OTUD1 levels, and significantly enhanced radiosensitivity in NPC cells. The gene discussed is OTUD1; the disease is nasopharyngeal carcinoma.